Download Citation
Article Source:
Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years
Olliaro PL,
Kuesel AC,
Halleux CM,
Sullivan M,
Reeder JC
(2018)
Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years.
PLOS Neglected Tropical Diseases 12(11): e0006837.
https://doi.org/10.1371/journal.pntd.0006837